Global healthcare company focused on pharmaceuticals, vaccines, and animal health products.
Merck & Co., Inc. operates globally as a healthcare company, divided into two main segments: Pharmaceutical and Animal Health. The Pharmaceutical segment focuses on developing and distributing a wide range of human health pharmaceuticals, including oncology treatments, hospital acute care medications, immunology therapies, and products for cardiovascular and diabetes management. It also manufactures vaccines for pediatric, adolescent, and adult preventive care.
In addition, Merck's Animal Health segment engages in the discovery, development, and distribution of veterinary pharmaceuticals, vaccines, and health management solutions. This segment also offers digitally integrated products for identification, traceability, and monitoring in the animal health sector. The company's clientele includes drug wholesalers, hospitals, government agencies, managed healthcare providers, veterinarians, and animal producers.
Merck & Co., Inc. collaborates with several prominent entities, including AstraZeneca PLC, Bayer AG, Eisai Co., Ltd., Ridgeback Biotherapeutics, and Gilead Sciences, Inc., to jointly develop and market long-acting HIV treatments. Founded in 1891, Merck & Co., Inc. is headquartered in Kenilworth, New Jersey, and continues to be a leader in advancing healthcare solutions globally.